Narrow-band UVB for the treatment of vitiligo: An emerging effective and well-tolerated therapy

International Journal of Dermatology

Volumn 44, Issue 1, 2005, Pages 57-60

  Kanwar, Amrinder Jit ^a   Dogra, Sunil ^a   Parsad, Davinder ^a   Kumar, Bhushan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT; PSORALEN;

ADOLESCENT; ADULT; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPIGMENTATION; DISEASE COURSE; ESTHETICS; FEMALE; FOLLOW UP; HUMAN; INDIAN; MALE; PATIENT COMPLIANCE; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRURITUS; SCHOOL CHILD; SKIN COLOR; SKIN PIGMENTATION; SPECTRAL SENSITIVITY; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO; XEROSIS;

ADOLESCENT; ADULT; CHILD; EXTREMITIES; FACE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NECK; PATIENT COMPLIANCE; SAFETY; SKIN PIGMENTATION; THORAX; TIME FACTORS; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY; VITILIGO;

EID: 13444292485     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02329.x     Document Type: Article

References (22)

1. Lerner AB. Vitiligo. Invest Dermatol 1959; 32: 285-310.
2. Lerner AB, Nordlund JJ. Vitiligo. What is it? Is it important? J Am Med Assoc 1978; 239: 1183-1187.
3. Howitz J, Brodthagen H, Schwartz M, Thomsen K. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113: 47-52.
4. Bolognia JL, Pawelek JM. Biology of hypopigmentation. J Am Acad Dermatol 1988; 119: 217-255.
5. Handa S, Kant I. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999; 26: 653-657.
6. Mattoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol 2002; 16: 573-578.
7. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
8. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
9. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
10. Tjioe M, Gerritsen MJ, Juhlin L, et al. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002; 82: 369-372.
11. Dogra S, Prasad D. Combination of narrowband UV-B and topical calcipotriene in vitiligo. Arch Dermatol 2003; 139: 393.
12. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-362.
13. Njoo MD, Spuls PI, Bos JD, et al. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Arch Dermatol 1998; 134: 1532-1540.
14. Njoo MD, Westerhof W, Bos JD, et al. The development of guidelines for the treatment of vitiligo. Arch Dermatol 1999; 135: 1514-1521.
15. Pathak MA, Mosher DB, Fitzpatrick TB. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5,8-trimethylpsoralen and psoralen in vitiligo. Natl Cancer Inst Monogr 1984; 66: 165-173.
16. Koster W, Wiskemann A. Phototherapy with UV-B in vitiligo. Z Hautkr 1990; 65: 1022-1024.
17. Al-Aboosi MM, Ajam ZA. Oral photochemotherapy in vitiligo: follow-up, patient compliance. Int J Dermatol 1995; 34: 206-208.
18. Norris DA, Horikawa T, Morelli JG. Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res 1994; 7: 193-203.
19. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991; 97: 410-416.
20. Fitzpatrick TB. Mechanisms of phototherapy in vitiligo. Arch Dermatol 1997; 133: 1591-1592.
21. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995; 105: 32-37.
22. Slaper H, Schothorst AA, Van der Leun JC. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients. Photodermatology 1986; 3: 271-283.